Dr. Ryan Pearson is an Associate Professor of Pharmaceutical Sciences and Director of the Bio- and Nano-Technology Center at the University of Maryland School of Pharmacy. He further holds an adjunct appointment in the Molecular Microbiology & Immunology department at the University of Maryland School of Medicine. Dr. Pearson received his Ph.D in Biopharmaceutical Sciences from the University of Illinois at Chicago and completed postdoctoral research at the University of Michigan. Dr. Pearson’s immune engineering laboratory focuses on developing nanoparticle-based technologies to treat dysregulated immune responses specifically focusing on sepsis, trauma, autoimmunity, and allergy. He has published over 40 manuscripts in top journals in the field, is an inventor on 3 granted patents, and has several additional patents pending. Dr. Pearson been recognized with multiple awards including the American Association of Colleges of Pharmacy New Investigator Award, National Institute for Pharmaceutical Technology and Education Rising Star Award, Shock Society Faculty Research Award, and the Maximizing Investigators’ Research Award (R35 MIRA) from NIGMS. Dr. Pearson serves on the editorial board of Pharmaceutical Research and Drug Delivery & Translational Research, and as faculty advisor for the AAPS UMB Student Chapter. He was the former Chair of the Immuno Delivery Focus Group for the Controlled Release Society and the AAPS Nanotechnology Community.